Kadoaki Ohashi
机构: Okayama University Hospital, Associate Professor
每年引用次数
引用次数
引用: 7,309
H-指数: 30
I10-指数 : 68
出版物: 229
Agent including reic/dkk-3 gene for treating egfr gene mutation positive lung cancer
Hiromi Kumon , Kadoaki OHASHI , Katsuyuki Kiura , Yoshinobu Maeda
2023
Early occurrence of epidermal growth factor receptor Mutation in lung adenocarcinoma: Comparison between pulmonary atypical adenomatous hyperplasia and adenocarcinoma
Katsuyuki Kiura , Yoshihiko Segawa , Akiko Hisamoto , Mitsune Tanimoto
Cancer Research 66 1066 -1067
2006
Abstract #LB-216: Effects of vandetanib on lung adenocarcinoma cells harboring an EGFR T790M mutation in vivo
Katsuyuki Kiura , Eiki Ichihara , Masayuki Yasugi , Daijiro Harada
Cancer Research 69
2009
Successful Treatment of a Patient with Gastric and Duodenal Metastases from Large Cell Carcinoma of the Lung with Carboplatin and Gemcitabine
Katsuyuki Kiura , Hideo Ino , Mitsune Tanimoto , Masahiro Tabata
Anticancer Research 26 4695 -4696
2
2006
[Appropriate use of granulocyte-colony stimulating factor].
Katsuyuki Kiura , Kadoaki Ohashi
Nihon rinsho. Japanese journal of clinical medicine 73 336 -340
2015
Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation
Katsuyuki Kiura , Eiki Ichihara , Masahiro Osawa , Mitsune Tanimoto
Acta Medica Okayama 70 ( 4) 243 -253
2016
Transgenic mice with mouse EGFR mutation developed lung adenocarcinoma
Katsuyuki Kiura , Minoru Takata , Tadashi Yoshino , Yoshiro Fujiwara
Cancer Research 67
1
2007
Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol
Daisuke Minami , Katsuyuki Kiura , Eiki Ichihara , Katsuyuki Hotta
Acta Medica Okayama 72 ( 3) 319 -323
4
2018
Effect of vandetanib on lung tumorigenesis in transgenic mice carrying activating EGFR mutation
Katsuyuki Kiura , Masahiro Osawa , Mitsune Tanimoto , Masahiro Tabata
Cancer Research 68 1126 -1126
2008
Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment Strategies
Katsuyuki Kiura , Kadoaki Ohashi , Go Makimoto , Go Makimoto
Acta Medica Okayama 74 ( 5) 371 -379
2020
Emergence of the EGFR T790M mutation in a lung adenocarcinoma cell line after vandetanib treatment
Katsuyuki Kiura , Eiki Ichihara , Hiromi Kashihara , Mitsune Tanimoto
Cancer Research 68 678 -678
1
2008
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)
Kiyotaka Yoh , Masahiro Morise , Azusa Tanimoto , Takashi Seto
Translational lung cancer research 10 ( 1) 314 -325
1
2021
Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients.
Katsuyuki Kiura , Eiki Ichihara , Katsuyuki Hotta , Susumu Kanazawa
Respiratory investigation 59 ( 2) 240 -246
2021
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 study.
Keisuke Aoe , Toyoaki Hida , Takashi Seto , Shunichi Sugawara
Cancer Science 112 ( 4) 1556 -1566
1
2021
Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease.
Kadoaki Ohashi , Kiichiro Ninomiya , Nobuharu Fujii , Yoshinobu Maeda
Internal Medicine
2021
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Katsuyuki Kiura , Eiki Ichihara , Katsuyuki Hotta , Masahiro Tabata
Japanese Journal of Clinical Oncology 51 ( 6) 956 -965
2021
A case of dramatic reduction in cancer-associated thrombus following initiation of pembrolizumab in patient with a poor performance status and PD-L1+ lung adenocarcinoma harboring CCDC6-RET fusion gene and NF1/TP53 mutations.
Katsuyuki Kiura , Katsuyuki Hotta , Koichi Goto , Toshio Kubo
Lung Cancer 156 1 -4
2021
Association with consolidation chemotherapy after concurrent chemoradiotherapyfollowed by surgery and the disease free survival in patients with stage III non-small cell lung cancer (NSCLC).
Yuka Kato , Katsuyuki Hotta , Go Makimoto , Takashi Ninomiya
Journal of Clinical Oncology 34
2016
Development of nationwide genomic screening project (LC-SCRUM-Japan) contributing to the establishment of precision medicine in Japan.
Takuma Yokoyama , Shingo Matsumoto , Kiyotaka Yoh , Takashi Seto
Journal of Clinical Oncology 34 ( 15_suppl) 9089 -9089
2016
Development of a nationwide genomic screening network for squamous cell lung cancer in Japan (LC-SCRUM-Japan).
Tadasuke Shimokawaji , Eri Sugiyama , Shingo Matsumoto , Kiyotaka Yoh
Journal of Clinical Oncology 34 ( 15_suppl) 9097 -9097
2016